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The biochemical basis that regulates the timely and selective
opening of the blood-testis barrier (BTB) to migrating prelepto-
tene/leptotene spermatocytes at stage VIII of the epithelial cycle in
adult rat testes is virtually unknown.Recent studies have shown that
cytokines (e.g. transforming growth factor (TGF)-3) may play a
crucial role in this event. However, much of this information relies
on the use of toxicants (e.g.CdCl2), making it difficult to relay these
findings to normal testicular physiology. Here we report that over-
expression of TGF-3 in primary Sertoli cells cultured in vitro
indeed perturbed the tight junction (TJ) barrier with a concomitant
decline in the production of BTB constituent proteins as follows:
occludin, N-cadherin, and ZO-1. Additionally, local administration
of TGF-3 to testes in vivowas shown to reversibly perturb the BTB
integrity and Sertoli germ cell adhesion via the p38MAPK and ERK
signaling pathways. Most importantly, the simultaneous activation
of p38 and ERK signaling pathways is dependent on the association
of the TGF-3-TR1 complex with adaptors TAB1 and CD2AP
because if TR1 was associated preferentially with CD2AP, only
Sertoli germ cell adhesion was perturbed without compromising
the BTB. Collectively, these data illustrate that local production of
TGF-3, and perhaps other TGF-s and cytokines, by Sertoli and
germ cells into the microenvironment at the BTB during spermat-
ogenesis transiently perturbs the BTB and Sertoli germ cell adhe-
sion to facilitate germ cellmigrationwhen the activatedTRI inter-
acts with adaptors TAB1 andCD2AP.However, TGF-3 selectively
disrupts Sertoli germ cell adhesion in the seminiferous epithelium
to facilitate germ cell migration without compromising BTB when
TRI interacts only with adaptor CD2AP.
In adult mammalian testes, such as rats, the blood-testis barrier
(BTB)2 is one of the “tightest” barriers in the mammalian body, compa-
rable with the blood-brain barrier (1–3). Yet the BTB must “open” (or
restructure/disassemble) at stages VII–VIII of the epithelial cycle to
accommodate the migration of preleptotene and leptotene spermato-
cytes across the barrier but remain “closed” at other stages throughout
spermatogenesis (4). Although detailed morphological studies of the
BTB were unraveled in the 1960s (5, 6), it remains a biological mystery
regarding how germ cells can traverse the BTB while the barrier func-
tion ismaintained during spermatogenesis. This is largely because of the
lack of a suitable in vivo model in the field to study BTB dynamics.
Recent studies have illustrated that the Sertoli cell tight junction (TJ)
permeability barrier is regulated, at least in part, by testosterone (7, 8),
possibly via its effects on the steady-state levels of occludin andZO-1 (7)
at the BTB. Furthermore, the BTB is utilizing a unique “engagement”
and “disengagement” mechanism between adherens junction (AJ) and
TJ to facilitate germ cell movement in which AJs (e.g. basal ectoplasmic
specialization (ES), a testis-specific cell-cell actin-based AJ type) can be
transiently disrupted without compromising the TJ barrier (9, 10). Yet
the biochemicalmechanism that induces transient TJ “opening” to facil-
itate germ cell migration is not known. Recent studies have shown that
TGF-3 administered to Sertoli cells cultured in vitro could perturb the
TJ barrier by reducing the protein levels of occludin and ZO-1 (11).
Interestingly, the cadmium-induced BTB restructuring in vivo was also
associated with an induction of TGF-3 and an activation of the p38
MAPK concomitant with a reduction in the protein levels of occludin/
ZO-1 and N-cadherin/-catenin at the BTB (12). Although results of
these in vivo studies were obtained by using animal models involving
toxicants, such as CdCl2, they have implicated the crucial role of
TGF-3 in BTB regulation. Because Sertoli and germ cells are both
known to produce TGF-3 (13, 14), we hypothesize that this cytokine
released locally to the microenvironment at the BTB may indeed be
used to regulate the opening of TJ at stage VIII of the epithelial cycle
via the p38 MAPK pathway. Furthermore, a recent study has illus-
trated that TGF-3 limits its action at the AJ (e.g. apical ES) without
perturbing the BTB integrity when only the ERK signaling pathway is
activated (15). We speculate that a unique mechanism is in place
involving adaptors, such as CD2AP (CD2-associated protein) and
TAB1 (TAK1-binding protein) (14), which selects the downstream
signaling events of TGF-3 so that it either induces restructuring at
the BTB and Sertoli germ cell adhesion or limits its effects on cell
adhesion without perturbing the BTB integrity. We thus sought to
delineate the intriguing interactions between the TGF-3-TRI pro-
tein complex and the two adaptors, CD2AP and TAB1, in the testis,
and how these interactions selectively activated the downstream sig-
nal transducers of TGF-3, which, in turn, led to restructuring at the
BTB and/or Sertoli germ cell interface. The testis apparently is using
such a novel mechanism to regulate restructuring at the Sertoli germ
cell interface to facilitate germ cell movement across the epithelium
during spermatogenesis while maintaining the BTB integrity. In the
course of this investigation, we have also unraveled a potentially
useful in vivo model to study BTB dynamics.
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EXPERIMENTAL PROCEDURES
Animals—Sprague-Dawley rats were purchased from Charles River
Breeding Laboratories (Kingston, NY) and were housed at the Rock-
efeller University Laboratory Animal Research Center with a 12:12-h
light/dark cycle with free access to water and standard chow. The use of
Sprague-Dawley rats for the studies described here was approved by the
Rockefeller University Animal Care and Use Committee with Protocol
Numbers 03017, 03040, and 06018.
Transient Transfection of Primary Sertoli Cell Cultures with Plasmid
Containing TGF3 cDNA and the Effects on Sertoli Cell TJ Permeability
Barrier—pCI-neo mammalian expression vector (Promega) containing
the full-length sequence encoding rat TGF-3 was prepared using the fol-
lowing specific primers (GenBankTM accession number NM_013174):
5-CTGGCCTCGTTCCTGAATTCACACATGAAGATG-3 (sense,
375–407); 5-TTCGCCTCCTCTGTTCTAGACTGGCCTCAGCT-3
(antisense, 1663–1632). Two bases (boldface) were mutated to create the
corresponding EcoRI and XbaI cloning sites (underlined). The authen-
ticity of this full-length clone was confirmed by direct nucleotide
sequencing prior to its use for subsequent experiments. For transient
transfection, Sertoli cells were isolated from 20-day-old rat testes to a
purity of greater than 95% as described previously (11, 16). Sertoli cells
were seeded on Matrigel-coated (diluted 1:5 with F-12/Dulbecco’s
modified Eagle’s medium; BD Biosciences) bicameral units (Millicell
HA filters, Millipore Corp.), 12-well plates, or cover glass at a density of
1.2  106/cm2, 0.5  106/cm2, or 0.15  106/cm2, respectively, and
cultured in F-12/Dulbecco’s modified Eagle’s medium at 35 °C in a
humidified atmosphere of 95% air, 5% CO2. Transfection was carried
out 2 days after isolation, using Effectene Transfection Reagent (Qia-
gen) with 0.3 g of plasmid DNA/6  105 Sertoli cells (plasmid/
enhancer (g/l) and plasmid/Effectene Reagent (g/l) were 1:8 and
1:15, respectively) following the protocols provided by Qiagen with a
transfection efficiency of 15% (see Table 1). Cells were incubated for
an additional 24 h in the transfecting mixture, and fresh F-12/Dulbec-
co’s modified Eagle’s mediumwas replaced. In preliminary experiments
to optimize transfection efficiency using either calcium phosphate co-
precipitation or Effectene reagent (Qiagen) (see Table 1), luciferase
reporter plasmid (pGL3-Control and pRL-TK; Promega) was co-trans-
fected into Sertoli cells with various combinations on the amounts of
plasmid DNA (0.1–3 g), different cell densities (0.1–1.2 106 cells/
cm2), and different incubation periods (4 h for calcium phosphate and
24 h for Effectene) to monitor the transfection performance under each
condition by assaying the luciferase reporter gene activity. An additional
parameter (i.e. different ratios of plasmid DNA to Effectene, ranging
between 1:10 and 1:25 were tested) was also assessed for transfection
efficiency using Effectene. Transfection efficiency was determined by
counting cells (at least 600 cells randomly in four randomly selected fields,
150 cells/field, under the microscope) with positive signals using either
fluorescencemicroscopy (for pTracer-CMV2which contains a green fluo-
rescent protein reporter) or immunohistochemistry staining of TGF-3
(for pCIneo), because non-TGF-3-transfected Sertoli cells had relatively
weak signals (see Fig. 1B). It is noted that counting transfected cells with
positive signals (e.g.-galactosidase or green fluorescent protein) is a com-
monapproach todetermine transfectionefficiency (17, 18).The integrityof
the Sertoli cell TJ permeability barrier and its changes following transient
transfection of TGF-3 versus various controls were estimated by quanti-
fying the transepithelial electrical resistance (TER) across the Sertoli cell
epitheliumwhen cells were cultured onMatrigel-coated bicameral units as
earlier described (11).
Transient Disruption of BTB Induced by Local Administration of
TGF-3; an in VivoModel for Studying BTB Dynamics—Groups of rats
(260–300 g bodyweight, n 3–4 per time point for each experiment,
with a total of four experiments conducted over a period of 2 years)
received human recombinant TGF-3 (catalog number PF073, Calbio-
chem) at 200 ng of TGF-3/testis (single dose, with amean S.D. testis
weight of about 1.65 0.15 g per testis, n 12) (regimen 1). Preliminary
experiments included administration of 80, 100, and 400 ng of recom-
binant TGF-3/testis for 1 or 2 doses (q  1 week) (n  2–3 rats per
time point), because results obtained from regimen 1 yielded clearly
distinguishable and reversible damage at the BTB; results reported
herein were representative data of these four experiments. This dosing
of 200 ng of recombinant TGF-3/rat testis that was selected is within
the physiological range of TGF-3 found in the adult rat testis. The
physiological level of TGF-3 in normal rat testes was estimated by
immunoblot analysis as follows. Testis protein lysates at 100, 200, and
300 g of total protein per lane were fractionated along with recombi-
nant TGF-3 at 1, 3, 5, 8, and 10 ng of protein per lane by SDS-PAGE (all
samples in duplicate). The resultant blot was immunostained with an
anti-TGF-3 antibody, and TGF-3 was visualized using an ECL kit
(Amersham Biosciences). Thereafter, the primary and secondary anti-
bodies in this blot were stripped in a stripping buffer (62.5mMTris-HCl,
pH 6.8, at 22 °C, containing 100mM20-mercaptoethanol, 2% SDS (w/v),
for 30 min in a reciprocating water bath, 40 rpm, at 55 °C), re-blocked
with 6% milk (w/v), and then re-probed with an anti-actin antibody to
assess equal protein loading. Protein bands corresponding to TGF-3
and -actin were scanned, and data were normalized against -actin
that served as a protein loading control. The amount of TGF-3 in testis
lysates was then interpolated from the resultant standard curve using
different amounts of recombinant TGF-3 (see above) by linear regres-
sion, plotting the area under the protein bands against protein levels.
This analysis had shown that each adult rat testis contained about 1.1
0.2 g of TGF-3 (n  4). For in vivo administration, TGF-3 was
resuspended and solubilized in 4mMHCl containing 0.1% bovine serum
albumin (w/v). Just prior to its use, it was diluted in PBS (10mM sodium
phosphate, 0.15 MNaCl, pH 7.4, at 22 °C) at 1:10 to a final concentration
of 1 ng/l, and administered to two different sites (about 100l per site,
see Fig. 3A, inset, for approximate location in the testis) intratesticularly
using a 27-gauge needle as described previously (19, 20), which is a
widely used methodology to assess effects of toxicants in the testis.
TABLE 1
A summary of experiments conducted in this laboratory for the past 2 years illustrating the transfection efficiency in overexpressing TGF-3
with different vectors in primary cultures of Sertoli cells
Vector a Transfection method tested (no. of experimentsconducted excluding preliminary experiments) Transfection efficiency Refs.
%
pGL3-Control and pRL-TK Calcium phosphate co-precipitation (n 2) ND 50–52
pCIneo/TGF-3 Calcium phosphate co-precipitation (n 4) 14.9 1.6
pTracer-CMV2/TGF-3 Calcium phosphate co-precipitation (n 3) 12.4 3.1
pGL3-Control and pRL-TK Effectene (n 2) ND 53
pCIneo/TGF-3 Effectene (n 6) 15.5 2.8
a All vectors were purchased from Promega except pTracer-CMV2, which was obtained from Invitrogen. ND indicates not determined.
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Vehicle controls referred to rats that received the same buffer contain-
ing no TGF-3. All glassware and plasticware used to handle TGF-3
were siliconized to minimize protein loss via nonspecific interactions.
Rats were terminated at different checkpoints (i.e. time point at which a
specific cellular event occurred) as follows: (i) time of TGF-3 injection
(time 0); (ii) time of appearance of BTB damage and germ cell loss (4
h to 2 days); (iii) time of BTB recovery (2–7 days); (iv) time of germ cell
repopulation (1–4 weeks); and (v) time of full recovery in which the
seminiferous epithelium was indistinguishable from controls (4
weeks). Controls included rats receiving the same volume of vehicle or
PBS alone administered by the 27-gauge needle as described, or no
treatment. As such, the BTB damage and the loss of Sertoli germ cell
adhesion in the testis as reported here following TGF-3 treatment are
not the result of an artifact such as an increase in fluid pressure in the
testis. Rats were terminated at specified time points by carbon dioxide
asphyxiation, and testes were either frozen in liquid nitrogen or pro-
cessed for paraffin sectioning. It is noted that the sites of TGF-3 (or
vehicle control) administration remained visible in testes for up to 2–4
weeks. As such, tissue blocks adjacent to these injection sites were cut
(0.1–0.2 g, which represented1/10 of the total testis) and were used
for lysate preparation in an IP Lysis Buffer (see below). About 3–4 serial
cross-sections from the three injection sites from each testis were used
for both frozen (for fluorescent microscopy) and paraffin (for hematox-
ylin and eosin staining) sections.
Transient Disruption of Anchoring Junctions in the Seminiferous Epi-
thelium without Compromising the BTB Integrity by Treating Rats with
Adjudin [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide], an in
VivoModel for Studying AJ Dynamics—For rats that received adjudin to
induce anchoring junction restructuring without compromising the
BTB integrity (for review see Ref. 3), adult rats (270–300 g, body
weight) were treated with a single dose of adjudin at 50 mg/kg body
weight by gavage as described (21). Adjudin was suspended in 0.25%
methylcellulose (w/vwithMilliQwater) at a concentration of 20mg/ml.
Rats in groups of3–5were sacrificed at specified time points following
treatment. Testes were immediately removed, frozen in liquid nitrogen,
and stored at80 °C until used. Control animals received vehicle con-
trol (i.e. the same volume of 0.25%methylcellulose suspended in water).
Elongating and elongate spermatids began to deplete from the seminif-
erous epitheliumby 8 h to 1 day after treatment, and50% of the round,
elongating, and elongate spermatids, as well as spermatocytes, were
depleted from the seminiferous epithelium in 90% of the tubules by
day 4 (21). However, the Sertoli tight junctions at the BTB were shown
to be unaffected during extensive anchoring junction restructuring that
accompanied germ cell loss from the tubules (3, 22). Thus, this adjudin
model was used to compare changes in the association between acti-
vated TRI upon coupling with TGF-3 and the adaptors CD2AP and
TAB1 when only Sertoli germ cell anchoring junctions were reversibly
disrupted without compromising the BTB integrity versus the TGF-3
model when both BTB and AJ were disrupted.
Fluorescence, Light and Electron Microscopy, and Immunohisto-
chemistry—Fluorescence microscopy using cross-sections of frozen
testes (6 m thickness) to co-localize different integral membrane
proteins (e.g. N-cadherin, occludin, and JAM-A) and adaptors (e.g.
-catenin, ZO-1) was performed essentially as described earlier (9, 15).
To visualize Sertoli cells following overexpression with TGF-3, cells
grown on cover glass were fixed in methanol at 20 °C for 10 min,
permeabilized with 0.2%TritonX-100 in PBS, blockedwith 10% normal
goat serum, and incubated with the corresponding primary antibody
pairs (see Table 2). For light microscopy, paraffin sections (6 m
thickness) were stained with hematoxylin and eosin. TGF-3-treated
TABLE 2
The sources of different antibodies and their working dilutions used for different experiments in this report
Vendor Target protein Animal source a Catalog no. Lot no. Usage b Working dilution
Santa Cruz Biotechnologies N-cadherin Rabbit sc-7939 J1502 IB 1:200
IP 1:100
IB 1:200
-Catenin Rabbit sc-7199 L0203 IF 1:100
IP 1:100
Nectin-3 Goat sc-14806 K261 IB 1:200
Actin Goat sc-1616 D052 IB 1:1000
p-Smad2/3 Rabbit sc-11769-R E2303 IB 1:200
TGF-3 Rabbit sc-82 H280 IB 1:200
IHC 1:150
IB 1:200
TR1 Rabbit sc-398 E0305 IP 1:100
IHC 1:150
CD2AP Rabbit sc-9137 J1204 IB 1:200
TAB1 Goat sc-6052 L0904 IB 1:200
Cell Signaling p-ERK (Thr202/Tyr204) Rabbit 9101S 13 IB 1:1000
ERK Rabbit 9102 10 IB 1:1000
p-p38 MAPK (Thr180/Tyr182) Rabbit 9211 10 IB 1:1000
p38 MAPK Rabbit 9212 3 IB 1:1000
JNK Rabbit 9252 4 IB 1:200
p-JNK Mouse 9255 10 IB 1:200
Zymed Laboratories Inc. IB 1:200
Occludin Rabbit 71–1500 30979485 IF 1:100
IP 1:100
N-cadherin Mouse 33–3900 30778768 IF 1:100
JAM-A Rabbit 36–1700 30979650 IB 1:250
IP 1:100
ZO-1 Rabbit 61–7300 50799336 IB 1:150
IP 1:100
ZO-1 Mouse 33–9100 40890448 IF 1:100
BD Transduction Laboratories Smad2/3 Mouse 610842 5 IB 1:500
Oncogene Research Products (San Diego) Pan-Ras Mouse OP40 D20224-1 IB 1:250
R & D Systems (Minneapolis, MN) TGF-3 Goat AF-243-NA AAT01 IB 1:500
a All primary antibodies used in this report were polyclonal antibodies prepared in rabbits or goats or were monoclonal antibodies prepared in mice. These antibodies
cross-reacted with the corresponding target proteins in rats.
b The abbreviations used are as follows: IB, immunoblotting; IP, immunoprecipitation; IF, immunofluorescence microscopy.
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FIGURE 1.Overexpression of TGF-3 in Sertoli cells cultured in vitro can perturb both TJ and AJ function. A, panels a–e, RT-PCR (panels a and b) and immunoblot (panels c–e)
analyses of primary Sertoli cells transiently transfected with a plasmid containing the TGF-3 full-length cDNA (pCIneo/TGF-3). Control (Ctrl), no treatment; Mock, transfection
performed without the plasmid DNA; pCIneo, plasmid alone without TGF-3 cDNA. The steady-state protein levels of occludin, ZO-1, N-cadherin, and TGF-3 were compared
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testes were examined, and150 seminiferous tubules were counted per
testis in each experimental group by scoring a total of randomly selected
tubules (600 tubules total) for each time point from four testes. In
brief, cross-sections of testes were placed under an Olympus BX40
microscope using a 10 objective, and 10 randomly selected fields were
photographed using an Olympus DP70 and printed using an Epson 890
Inkjet printer. Damaged tubules were then scored and defined by those
tubules with elongated spermatids (n10, except for stage IX tubules),
round spermatids, and/or spermatocytes (n  5) found in the tubule
lumen as described (15). Changes in tubule diameters were also scored
(16). The scoring of tubules was conducted by two separate investiga-
tors using coded slides, and resultswere analyzed and decoded by a third
investigator to obtain unbiased composite data. Immunohistochemistry
staining of TGF-3 and TR1 using frozen sections of testes (7m in
thickness) was performed essentially as described previously (15), and
the antibody dilutions that were used for these experiments are shown
in Table 2. Controls include sections incubated with normal rabbit IgG
in stead of the primary antibody against TGF-3. For all morphology
studies, different samples within a treatment group versus controls were
processed in a single experimental session using cross-sections of testes
(3–4 sections per glass slide) so that all sectionswere treated similarly,
including primary and secondary antibodies and/or color development.
Electron microscopy was performed at the Rockefeller University Bio-
Imaging Facility (12). In brief, rats treated with 200 ng of TGF-3 per
testis or with vehicle control were terminated on day 2 by CO2 asphyx-
iation. Testes were removed, incised to release the seminiferous tubules,
and fixed in a 0.1 M sodium cacodylate buffer, pH 7.4, at 22 °C, contain-
ing 2.5% glutaraldehyde (v/v) for 4 h, followed by post-fixation in
OsO4 (1%) and staining in 1%uranyl acetate. Tissueswere dehydrated in
ascending concentrations of ethanol, incubated in propylene oxide, and
then infiltrated with EMbed (Electron Microscopy Sciences, Fort
Washington, PA). Ultrathin sections (80 nm thickness) were cut using
a Reichert-Jung Ultracut E microtome (Bannockbum, IL) and post-
stained with uranyl acetate/lead. Cross-sections of tubules were then
examined and photographed on a JEOL 100CXII Electron Microscope
(Peabody, CA) at 80 kV. Although only a representative set of experi-
ments was reported here, all experiments were repeated at least three
times (excluding preliminary experiments to select the appropriate anti-
body titers and primary/secondary antibody incubation conditions)
using testes from different animals or Sertoli cells from different exper-
iments, and similar results were obtained in these experiments.
RT-PCR, Immunoblottings, Co-immunoprecipitation (Co-IP), and
Intrinsic p38 and ERK Assays—Semi-quantitative RT-PCR and immu-
noblottings were performed as described (11, 15). In selected experi-
ments where Sertoli cells were transiently transfected with the full-
length TGF-3 cDNA, the steady-state levels of total p38 MAPK,
ERK1/2, the JNK versus the corresponding activated (phosphorylated)
were also estimated by immunoblottings to monitor if any of these
downstream signal transducers were being activated. Cell lysates were
obtained by solubilizing proteins from Sertoli cells cultured in 6-well
dishes (in triplicate) using lysis buffer (10 mM Tris, pH 7.4, at 22 °C,
containing 1% SDS (w/v), 1.6 2-mercaptoethanol, 1 mM EGTA, 2 mM
phenylmethylsulfonyl fluoride, 2 mM N-ethylmaleimide) (10 min at
room temperature, followed by centrifugation at 15,000 g for 15 min
at 4 °C to obtain the clear supernatant that served as the lysate). Co-IP
was performed as detailed elsewhere (9). In brief, testis lysates (500g
of protein per sample) prepared in an IP Lysis Buffer (10 mM Tris, pH
7.4, at 22 °C, containing 0.15 M NaCl, 2 mM phenylmethylsulfonyl fluo-
ride, 1 mM EGTA, 1% Nonidet P-40 (v/v), 1 mM sodium orthovanadate,
1g/ml leupeptin, 1g/ml aprotinin, and 10% glycerol (v/v)) from each
sample was used for Co-IP. Equal amounts of testis lysates (125 g of
protein/sample) estimated by Coomassie Blue dye-binding assay (23) or
extracted immunocomplexes from Co-IP experiments were used for
immunoblottings and probed for different target proteins (see Table 2).
Intrinsic ERK and p38 MAPK assays were performed using specific
p-ERK and p38 MAPK assay kits (Cell Signaling) with the correspond-
ing fusion proteins Elk-1 and ATF-2. The corresponding activated
(phosphorylated) transcription factors, namely p-Elk-1 and p-ATF-2,
were visualized by immunoblottings using specific antibodies provided
in the kits. Proteins were visualized by using chemiluminescence kits
obtained from Amersham Biosciences. Each experiment was repeated
at least three times using data fromdifferent animals. All samples within
an experimental groupwere processed simultaneously in an experimen-
tal session to eliminate inter-experimental variations. Data were densi-
tometrically scanned using SigmaGel (version 3.0) from SPSS Inc.
Image and Statistical Analyses—Gel images from RT-PCR and
immunoblots were scanned using SigmaGel software (SPSS Inc., ver-
sion 1.05). One-way ANOVA to be followed by the Tukey’s honestly
significant test was performed using the JMP IN statistical analysis soft-
ware package (version 4; SAS Inc., Cary, NC).
RESULTS
Overexpression of TGF-3 in Sertoli Cells Disrupted Both TJ
and AJ Integrity in Vitro
Primary Sertoli cells cultured in vitro were transfected with plasmids
containing the full-length TGF-3 (pCIneo/TGF-3) with 15% effi-
ciency. About 24 h after transfection, both the steady-state mRNA (Fig.
1, A, panels a, and b) and protein levels of TGF-3 increased signifi-
cantly (Fig. 1, A, panels c and d), concomitant with a significant reduc-
tion in occludin, ZO-1, and N-cadherin (Fig. 1A, panels a--d), suggest-
ing both the TJ and AJ function were perturbed. Overexpression of
TGF-3 in Sertoli cells, but not with empty vector, was also shown to
induce activation (i.e. phosphorylation) of p38 and ERK MAP kinases
but not JNK (Fig. 1, A, panels c and e). These results are also consistent
with recent in vitro and in vivo findings investigating the regulatory roles
of TGF-3 on BTB dynamics (15, 24). As shown in Fig. 1B, panel a,
intact TJ fibrils formed in part by occludin (green) and its adaptor ZO-1
(red) was detected and co-localized at the Sertoli interface. Transfection
of Sertoli cells with pCIneo/TGF-3, however, not only reduced the
protein levels of occludin and ZO-1 at the cell-cell interface but also
caused significant disruption of the immunoreactive “belt-like” struc-
ture, an indication of broken TJs between Sertoli cells. This effect was
not seen in cells transfected with empty vector (Fig. 1, B, panel c versus
panel b). Likewise, overexpression of TGF-3 (red fluorescence in Fig.
1B, panel e) also affected N-cadherin and ZO-1 levels and their distri-
bution versus control (Fig. 1B, compare panels d and f with e and g).
Furthermore, we monitored the effects of TGF-3 overexpression in
(panels c and d). The steady-state protein levels of p38, ERK, and JNKMAP kinases, and their corresponding activated (i.e. phosphorylated) forms in cells with transient transfection of
TGF-3 cDNA versusother controlswere also assessed (panel e).-Actin servedas aprotein loading control.B, fluorescentmicrographsof Sertoli cells transfectedwithpCIneo/TGF-3
versus control and pCIneo alone. Cells were stained with different target proteins (e.g. occludin, N-cadherin, and ZO-1) and TGF-3.White arrowheads depict the TJ or basal ES site
where protein(s) formed an intact belt-like barrier between neighboring Sertoli cells; white arrows indicate the disrupted TJ barrier, manifested by the broken belt-like structures;
asterisks indicate TGF-3 staining. C, TER of Sertoli cells cultured in bicameral units that were transfected with pCI-neo/TGF-3 versus controls. Each data point is the mean S.D. of
three experiments. ns, not significantly different by ANOVA; *, p 0.05; **, p 0.01; n.d., not detectable.
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Sertoli cells on the TJ barrier functionally by quantifying the TER across
the Sertoli cell epithelium onMatrigel-coated bicameral units (Fig. 1C).
Transient transfection was performed on day 2 when Sertoli cells had
formed a functional TJ barrier (11, 16). Consistent with results by
immunoblottings and fluorescence microscopy, overexpression of
TGF-3 indeed disrupted the TJ permeability barrier by reducing TER
by2-fold versus controls (15–20 ohmscm2 versus 35–40 ohmscm2 in
controls) (Fig. 1C).
TGF-3 and TR1 Expression in the Seminiferous Epithelium
It is known that TGF-s are multifunctional molecules that affect
numerous testicular function, including steroidogenesis, cell differenti-
ation, and germ cell development (for a review see Ref. 14). It is conceiv-
able that if TGF-3 indeed plays a crucial role in regulating BTBdynam-
ics in vivo, TGF-3 and its receptor should reside close to the BTB.
Furthermore, its expression should be peaked in the seminiferous epi-
thelium at stages VII–VIII when preleptotene and leptotene spermato-
cytes are traversing the BTB. Although an early study reported the
enhanced expression of TGF-3 at stage VII–VIII (24), its pattern of
localization in the seminiferous epitheliumof a stageVIII tubulewas not
shown. We have thus performed a detailed immunohistochemistry
analysis as shown in Fig. 2. Consistent with this earlier study (24),
TGF-3 was found to be highly expressed in stages V–VIII tubules;
however, its staining was greatly reduced at stages X–XIII (see Fig. 2A,
panels a and b versus c and d, including insets in themicrographs, which
are the lower magnifications of the corresponding micrographs show-
FIGURE2.Astudy toexamine the localizationandstage specificityof TGF-3andTR1 in the seminiferousepitheliumofadult rat testesby immunohistochemistry. Frozen
sections (7m in thickness) of testes from adult rats (300 g body weight) and an antibody against either TGF-3 (A) or TR1 (B) (see Table 2) were used for immunohistochemistry
using procedures as described (9). A, TGF-3 was predominant at stages V–VIII tubules; its staining was reduced at stages X–XIII (see panels a and b versus panels c and d, including
insets showing the lower magnifications of the correspondingmicrographs). At stages VII and VIII, intense staining of TGF-3 in the epithelium as shown in panel b (see also inset to
panel b) is consistentwith its localization at the BTB. Panel e, this is a control section stainedwith normal rabbit IgG, illustrating the staining shown in panels a–d is specific for TGF-3.
In panel f, this is an immunoblot using 5 ng of recombinant human TGF-3 and 100g of protein of testis lysate and stainedwith the anti-TGF-3 antibody, illustrating the specificity
of this antibody. Bar in panel a 50m; bar in inset 200m,which also applies to panels b–e. Because an increase in TGB-3 staining as reported here and elsewhere (15, 24) was
not just associated with stages VII–VIII tubules, we speculate that its increase in the epithelium at stages V–VI may have other physiological functions, plausibly unrelated to
preleptotene/leptotene spermatocyte migration across the BTB that occur at VII–VIII. This is not entirely unexpected because TGF-3 affects multiple testicular function (14, 33). B,
these micrographs illustrate the immunohistochemical localization of TR1 in the seminiferous epithelium of adult rat testes. TR1 did not display the same stage specificity as of
TGF-3 (see panel a in B versus panels a–f in A). Instead, TR1was detected in the epithelium in almost all stages of the epithelial cycle, but it was found at the site consistent with its
localization at the BTB (see the right panel in panel a, which is themagnified view of panel a). In panel b, this is an immunoblot using 100g of protein of adult rat testis lysate stained
with the anti-TR1 antibody, illustrating the specificity of the antibody. Bar in panel a 50 m; bar in inset 200 m; bar in right panel 25 m; D.F., dye-front.
balt3/zbc-bc/zbc-bc/zbc02506/zbc5559-06g saylora S3 2/5/06 15:18 4/Color Figure(s) F1–3,6,8 ARTNO: M601618200
TGF-3 and Adaptors in Blood-Testis Barrier Dynamics
6 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER ?? •???? ??, 2006
F2
ing more staged tubules). At stages VII and VIII, the intense staining of
TGF-3 in the seminiferous epithelium as shown in Fig. 2A, panel b (see
also inset to panel b), is consistent with its localization at the BTB near
the basal lamina. Significant amounts of immunoreactive TGF-3 was
also detected in the seminiferous epithelium and was associated with
round spermatids (see Fig. 2A, panels a–d). This is not entirely unex-
pected because TGF-3 was shown to have other physiological func-
tions in the testis (e.g. germ cell development) (for reviews see Refs.
14 and 25) other than its involvement in BTB dynamics as reported
here. In Fig. 2A, panel e, this is the section stained with the normal
rabbit IgG, illustrating the staining shown in panels a–d is specific
for TGF-3. In Fig. 2A, panel f, this is an immunoblot using recom-
binant human TGF-3 and testis protein lysate and is stained with
the anti-TGF-3 antibody, illustrating the specificity of this anti-
body. Fig. 2B illustrates the immunohistochemical localization of
TR1 in the seminiferous epithelium of adult rat testes. Interest-
ingly, TR1 did not display the same stage specificity as of TGF-3
(see a in Fig. 2B versus a–f in A). Instead, TR1 was detected in the
seminiferous epithelium in almost all stages of the epithelial cycle,
but it was also found at the site consistent with its localization at the
BTB (see the right panel in Fig. 2B, panel a, which is the magnified
view of the boxed area in a). The results shown in Fig. 2B did not
negate the significance of the stage-specific induction of TGF-3
detected in stages V–VIII as shown in Fig. 2A; in contrast, they
FIGURE 3. Effects of local administration of TGF-3 to rat testes on the status of spermatogenesis and the kinetics of germ cell loss from the epithelium. A, recombinant
TGF-3 or vehicle (Veh) was injected into the testis using a 27-gauge needle at2 sites/testis (see yellow arrowheads) at time 0 (i.e. Ctrl, control) (see inset to A). The weight of testes
did not alter during the treatment (data not shown). B–H, representative photographs of paraffin sections stained with hematoxylin and eosin from testes treated with TGF-3 at
specified time points; the vehicle control is shown in A. Morphometric changes (% of tubules with germ cell exfoliation and shrinkage of tubule diameter) of the tubules are
summarized in thebargraph shown in I.Asterisk indicate tubuleswithnotablegermcell loss;arrows indicategermcells, suchas spermatocytes and round spermatids, andwere found
in the tubule lumen; arrowheads indicatemultinucleated germ cells, an indication of either necrosis or a collapse of germ cell syncytium that occurs prior to apoptosis. Bar 120m
in A and applies to all graphs except for themagnified views of the corresponding boxed areaswhere bar 40m. ns, not significantly different by ANOVA; *, p 0.05; **, p 0.01.
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reinforce the notion as described above that TGF-3 is crucial to
other seminiferous epithelial function in addition to BTB dynamics.
In Fig. 2B, panel b, this is an immunoblot using adult rat testis pro-
tein lysate stained with the anti-TR1 antibody, illustrating the spec-
ificity of the antibody used for immunohistochemistry shown in Fig.
2B. In short, these experiments illustrate that TGF-3 and its recep-
tor, TR1, are present at the BTB site, and the stage-specific expres-
sions of TGF-3 in the epithelium are consistent with their involve-
ment in BTB dynamics.
An in VivoModel for Studying BTB and AJ Dynamics
Changes in the Status of Spermatogenesis following TGF-3
Treatment—To test if local administration of TGF-3 reversibly
perturbed the BTB in vivo, TGF-3 (200 ng/testis) was administered
to the testis via intratesticular injection at two sites (see Fig. 3A,
inset). Although this treatment did not elicit any significant changes
in testis weight over the 4-week experiment period (data not shown),
histological analysis of these testes revealed that TGF-3 caused
germ cell depletion from the epithelium, which was limited to elon-
gate/elongating/round spermatids and some late spermatocytes (Fig.
3, A–H). This disruptive effect on Sertoli germ cell interface was not
detected by 30 min post-treatment, but some signs of damage were
visible by 4 h; this effect was most prominent at 24–48 h when the
damaged tubules were40% in the epithelium, and the tubule diam-
eters shrunk by 20% (Fig. 3, C–G versus A and B). This damaging
effect began to recede by 1 week (Fig. 3H), and by 4 weeks most of the
tubules (97%) were indistinguishable from controls (Fig. 3I). This
time frame of germ cell depletion followingTGF-3 treatment and their
repopulation in the epithelium also suggests that most of the spermato-
cytes were not affected so that they can repopulate the seminiferous
epithelium within 20 days, consistent with the micrographs shown
in Fig. 3. In this context, it is of interest to note that the phagocytic
FIGURE 4. Ultrastructural changes in the testis
on day 2 after treatment with TGF-3 (200
ng/testis), A, B, and E indicate vehicle controls;
C, D, and F indicate treatment group. A and B,
the cross-section of a normal seminiferous tubule
fromadult rat testes showing the epithelium lying
on the basement membrane (white asterisks) and
the BTB (boxed area) was magnified and is shown
in B. BTB is composed of TJ (black arrowheads) co-
existing with basal ES, which is typified by the
presenceof actinbundles (white arrowhead) sand-
wiched between cisternae of endoplasmic reticu-
lum (ER) and Sertoli cell (SC) membrane that is
clearly visible on both sides of the Sertoli cells
(apposing black arrowheads represent two appos-
ing SC membranes). C and D, the BTB in TGF-3-
treated testes displayed obvious structural dam-
ages in which the ER and the actin filament
bundles were dissolving (see black arrowheads)
with the presence of swelling intercellular space
between the two SCs (see asterisks). E, typical api-
cal ES in the seminiferous epithelium of normal
rats between elongating spermatids (Nu, nucleus)
and SC in which actin bundles (white arrowheads)
sandwiched between SC membrane and ER and
restricted to the SC. F, both actin bundles and ER
were defragmented, disappearing from the apical
ES (black arrowhead) in TGF-3 treated testis. Ac,
acrosome. Bar: A, 0.5m; B, D, and F, 0.2m;C and
E, 1 m.
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FIGURE 5.Changes in different target proteins, includingMAPkinases in testes during TGF-3-inducedBTB andAJ disruption in the testis. A, immunoblot analysis to assess
the changes of protein levels after TGF-3 treatment in the rat testis. These include the representative integral junctionmembrane proteins and their adaptors at the BTB and apical
ES, the threeMAP kinases, and Smad2/3 and their corresponding phosphorylated (activated) forms (panel a). Parallel immunoblot analysis of these proteins in the testes of adult rats
received vehicle control (panel b). B, densitometric scanned data of immunoblots such as those shown in A. Each bar is the mean S.D. of three independents sets of samples from
different experiments. C, intrinsic kinase activity of ERK (substrate, Elk-1) and p38 (substrate, ATF-2) (left panel), and these datawere also summarized in the right panel (n 3). ns, not
significantly different by ANOVA; *, p 0.05; **, p 0.01; h, hour; d, day.
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activity of Sertoli cells appeared to be activated by TGF-3 treatment
as shown in Fig. 3, which is likely the result of an increase in germ cell
necrosis as shown by the multinucleated cells seen here (e.g. Fig. 3, F
and H). At present, it is not known if an increase in phagocytosis is
associated with the transient BTB disruption.
Ultrastructural Changes at the BTB following TGF-3 Treatment—
The ultrastructural changes after TGF-3 treatment were also exam-
ined by electron microscopy and are shown in Fig. 4. In normal testes,
BTB that was composed of co-existing TJ and basal ES was readily
visible (see boxed area in Fig. 4A, which ismagnified in Fig. 4B). Basal ES
was typified by the presence of actin bundles (white arrowheads in Fig.
4) sandwiched between apposing Sertoli cell membranes (apposing
black arrowheads) and the cisternae of the endoplasmic reticulum (ER),
coexisting with TJ (black arrowheads) at the BTB (Fig. 4B). However, by
2 days after TGF-3 treatment (200 ng/testis), the voided intercellular
space was frequently found between apposing Sertoli cell membranes at
the BTB (black asterisks), coupled with defragmentation of actin bun-
dles (black arrows) (Fig. 4,C andD), illustrating a disruption of the BTB.
Apical ES between spermatids and Sertoli cells, a structure similar to
basal ES but the actin filament bundles and the cisternae of ER were
found only on the Sertoli cell side, was also found to be disrupted after
TGF-3 treatment (Fig. 4, F versus E). For instance, the actin bundles at
the apical ES in normal testes (see white arrowheads in Fig. 4E) were
found to become extensively disorganized with the simultaneous loss of
the ER at the apical ES (black arrowheads in Fig. 4F). These results
illustrate that TGF-3, when administered locally, was capable of dis-
rupting both TJ and basal ES at the BTB and apical ES.
Changes in Target Protein Levels in the Seminiferous Epithelium and
Intrinsic Kinase Activities of p38 and ERK MAPK during TGF-3-
induced BTB and AJ Damage—By using immunoblottings, the steady-
state levels of target junction junctions/adaptors at the BTB and ESwere
analyzed (Fig. 5). The occludin level was significantly reduced between
4 h and 1 week, being most severe at 1–2 days to50% of control (Fig.
5, A and B). By 1–2 days, the ZO-1 level was also reduced significantly
(Fig. 5). JAM-A, another TJ integral membrane protein in the testis,
however, was unaffected (Fig. 5). There was also a decline inN-cadherin
and nectin-3 (an AJ protein restricted to spermatids (26)) but not the
adaptor protein-catenin (Fig. 5). Furthermore, TGF-3 activated both
the ERK and p38 MAPK signal transducers but not JNK or Smad2/3.
These observations appeared to be specific to the TGF-3 treatment
because testes from rats treated with vehicle alone (see “Experimental
Procedures”) exhibited no changes in the levels of these junction/adap-
tor proteins nor phosphorylation of any three MAP kinases (Fig. 5A,
panel b) An activation of p-ERK and p38MAPK was further confirmed
by specific intrinsic kinase assays for the corresponding MAPKs during
TGF-3-induced BTB and AJ disruption because the putative sub-
strates, namely transcription factors p-Elk-1 and p-ATF-2, specific for
p-ERK and p38, respectively, were indeed significantly induced by
TGF-3 treatment (Fig. 5C).
Reversible BTB Damage after TGF-3 Treatment—We next exam-
ined the distribution of occludin/ZO-1 (Fig. 6A), N-cadherin/-
catenin (Fig. 6B), and JAM-A/ZO-1 (Fig. 6C) in testes from rats by 2
days and 2 weeks after TGF-3 treatment versus control testis using
fluorescence microscopy to monitor the BTB integrity (Fig. 6). In
normal testes, occludin, JAM-A, and N-cadherin were localized with
their adaptors ZO-1 and -catenin at the basal compartment of the
seminiferous epithelium, consistent with their localization at the
BTB (Fig. 6, A–C). More importantly, this loss of occludin, ZO-1,
and N-cadherin, but not -catenin, from the epithelium was tran-
sient (Fig. 6, A and B), because by week 2 these proteins were found
to localize at the BTB site virtually indistinguishable from control
testes (Fig. 6, A, panels i--l, and B, panels i--l) and consistent with the
results of immunoblottings (Fig. 6 versus Fig. 5). It must be noted that
this technique, when used in conjunction with immunoblottings, is a
powerful tool to accurately monitor BTB integrity, and is indistin-
guishable from the more tedious techniques, such as micropuncture,
to quantify the diffusion of 125I-labeled bovine serum albumin from
the system circulation to rete testis and seminiferous tubule fluids to
assess BTB integrity (12, 27).
The Activated TGF3-TR1 Complex Recruits Either Adaptors CD2AP
and TAB1 or CD2AP Alone to the BTB to Selectively Activate Different
MAPK Signal Transducers
When TGF-3 binds to its receptors (type II, TRII, and type I,
TR1), the ligand-receptor complex, in turn, recruits different adap-
tors to phosphorylate selective downstream kinases, leading to an
activation of distinct MAP kinase(s), thereby regulating different
physiological events (14, 28, 29). As shown in Fig. 7A, adaptors
CD2AP and TAB1 were indeed expressed by both Sertoli and germ
cells even though they are not uniformly distributed in these two cell
types (Fig. 7A). Furthermore, CD2AP was shown to associate with
N-cadherin, -catenin, ZO-1, and JAM-A, but not occludin, in
lysates of normal seminiferous tubules, unlike TAB1 which was
shown to associate with all these proteins (Fig. 7B). Results shown in
Fig. 7B were consistent with recent observations that CD2AP was
localized predominantly to the basal compartment at the BTB in rat
testes by immunohistochemistry3 and in mouse testes (30), co-exist-
ing with N-cadherin, -catenin, ZO-1, and JAM-A (9, 15). In adju-
din-treated rat testes, it was shown that the loss of germ cells from
the epithelium was associated with a transient TGF-3 induction,
and an activation of ERK but not p38 MAPK, which led to AJ disrup-
tion and germ cell loss from the epithelium without compromising
the BTB integrity (15). As such, these two models, namely the
TGF-3 and adjudin models, provide the means to identify the
intriguing protein-protein associations between TGF-3/TR1 and
TAB1 and/or CD2AP when both BTB and Sertoli germ cell adhesion
(the TGF-3 model) or only Sertoli germ cell adhesion (the Adjudin
model) was perturbed. When samples from both models were ana-
lyzed simultaneously in a single experimental session to eliminate
inter-experimental variation and as shown in Fig. 7, C–F, it was
noted that by using an anti-TR1 antibody as the precipitating anti-
body, it could pull out significantly more CD2AP and TAB1 as well as
Ras GTPase by 4 h to 1 day when the BTB and Sertoli germ cell
adhesion was disrupted in the TGF-3 model, whereas the level of
TRI per se remained relatively constant (Fig. 7C). When the lysates
from these samples were examined by immunoblottings and com-
pared with Co-IP data (right panel versus middle panel in Fig. 7C), it
was noted that the relative protein levels of CD2AP, Ras, and TRI
did not change with TGF-3 treatment except that TAB1 was
induced2-fold by 4 h (see Fig. 7D), but there was an increase in the
association between TRI and adaptors CD2AP and TAB1 at the
time of BTB and Sertoli germ cell adhesion disruption (Fig. 7, C and
D). By using samples from the adjudin model when only Sertoli germ
adhesion was disrupted without perturbing the BTB integrity (3), it
was noted that there was a significant increase in the protein-protein
association between TRI and CD2AP and Ras GTPase by 8 h and 1
day post-treatment, but an2–3-fold decline in association between
TRI and TAB1 by 1 and 4 days (see Fig. 7, E and F). However, the
3 W. Xia and C. Y. Cheng, unpublished observations.
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steady-state protein levels of CD2AP, Ras, and TRI remained rela-
tively stable except for a decline in TAB1 level by day 4 when lysates
of these samples were analyzed (right versus middle panel in Fig. 7E,
see also Fig. 7F). Fig. 7, C and E, last panel in the left column, shows
the IgG heavy chain in the Co-IP experiment, illustrating equal pro-
tein loading and uniform protein transfer. In short, these data illus-
trate (see Fig. 8) that when CD2AP was associated with the TGF-3-
TRI complex, the ERK signaling pathway was activated, leading to
a reversible disruption of Sertoli germ cell adhesion without compro-
mising the BTB. However, when TAB1 and CD2AP were both asso-
FIGURE 6. A study to assess the reversibility of
the TGF-3-induced BTB damage by fluores-
cence microscopy. Cryosections (7 m) of tes-
tes from vehicle control, 2 days and 2 weeks after
TGF-3 treatment, were stained with different
antibody pairs for occludin and ZO-1 (A), N-cad-
herin and -catenin (B), JAM-A and ZO-1 (C) to
visualize their localization at the BTB. Bar in a 80
m, which applies to remaining graphs. A tran-
sient loss in occludin, ZO-1, and N-cadherin, but
not -catenin or JAM-A, was readily detected (see
A–C, panels e–h versus panels a–d and i–l). DAPI,
4,6-diamidino-2-phenylindole.
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FIGURE 7. TGF-3 activates specific MAP kinases by recruiting different switching adaptors to the activated TR1 in the testis. A, immunoblots using lysates of testes (Te),
seminiferous tubule (ST), Sertoli cells (SC), and germ cells (GC) showing relative abundance of two adaptors: CD2AP (80 kDa) and TAB1 (56 kDa) versus TR1 (53 kDa) (right panel).
-Actin served as the protein loading control. The left panel is the histogram with n  4 using different samples. B, interactions of typical BTB-associated proteins: N-cadherin,
-catenin, occludin, ZO-1, and JAM-AwithCD2APor TAB1byCo-IP using seminiferous tubule lysates.C,protein lysates (500gof protein/sample) fromTGF-3-treated testeswere
used for Co-IPwith an anti-TR1antibodyduringBTB restructuring, and theblotwasprobed for CD2AP, Ras (21 kDa), TAB1, andTR1. Protein lysates (100gof protein/lane)without
Co-IP (see right panel) or with normal rabbit IgG served as positive and negative controls, and -actin and IgGH served as protein loading controls which also illustrated uniform
balt3/zbc-bc/zbc-bc/zbc02506/zbc5559-06g saylora S3 2/5/06 15:18 4/Color Figure(s) F1–3,6,8 ARTNO: M601618200
TGF-3 and Adaptors in Blood-Testis Barrier Dynamics
12 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER ?? •???? ??, 2006
ciated with the TGF-3-TRI complex, both the p38 and the ERK
signaling pathways were activated, which, in turn, led to a transient
and reversible disruption of the BTB and Sertoli germ cell adhesion.
DISCUSSION
TGF-3 Is a Crucial Regulator of Junction Dynamics Pertinent to
Spermatogenesis—TGF-3 regulates multiple testicular functions, such
as Leydig and germ cell proliferation, extracellular matrix synthesis,
testis development, and follicle-stimulating hormone action (for
reviews see Refs. 13, 14, and 31–33). Recent studies have shown that
TGF-3 is predominantly expressed by Sertoli and germ cells at the
BTB site in the seminiferous epithelium at stages, including VII–VIII, of
the epithelial cycle (24) (see also Fig. 2), coinciding with the events of
spermiation and the migration of preleptotene/leptotene spermato-
cytes across the BTB (4, 34). Subsequent studies using specific inhibitors
against different MAP kinases have shown that TGF-3 also regulates
Sertoli cell TJ dynamics in vitro and in vivo via the p38MAPK signaling
pathway in studies involving cadmium (12, 24, 35), an environmental
toxicant known to disrupt BTB (36, 37). These earlier findings coupled
with the data reported herein have prompted us to speculate that at late
stageVII through stageVIII of the epithelial cycle, Sertoli, and germcells
contribute to an elevated level of TGF-3 by secreting this cytokine to
themicroenvironment at the BTB. In turn, this activates theTRI resid-
ing on Sertoli cells, recruiting adaptors CD2AP and TAB1 to the BTB
and further activating the p38MAPK and ERK signaling pathways. The
net result of this interaction reduces the protein levels of both occludin/
ZO-1 and cadherins at the BTB, as well as cadherins at the apical ES,
perturbing both the TJ barrier and Sertoli germ cell adhesion and
thereby transiently disrupts BTB and apical ES to facilitate both prelep-
totene/leptotene spermatocyte migration across the BTB and spermia-
tion at apical ES (see Fig. 8). Whereas at other stages of the epithelial
cycle, CD2AP, but not TAB1, is predominantly recruited to the TGF-
3-TR1 protein complex, and the ERK pathway is preferentially acti-
vated to perturb Sertoli germ cell adhesion to facilitate germ cell move-
ment across the seminiferous epithelium without compromising the
BTB integrity. In short, CD2AP and TAB1 work as molecular switches
that turn “on” and “off” of the TGF-3-mediated p38/ERK or ERK sig-
naling pathways in coordination with the epithelial cycle during sper-
matogenesis. Needless to say, the detailed biochemical event that acti-
vates the downstream signaling pathways following the recruitment of
the two adaptors to the microenvironment at BTB remains to be eluci-
dated. It is obvious that other kinases and phosphatases are involved
because adaptors are known to serve as platforms for signal transduc-
tion by recruiting other regulatory proteins to the site besides tethering
the integral membrane proteins to the actin or intermediate-based
cytoskeleton (38). Even though the BTB at the basal compartment and
the apical ES at the luminal edge of the seminiferous epithelium are
morphologically distinct entities, they are the integral ultrastructures at
the opposite ends of adjacent Sertoli cells. This molecular “switching”
mechanism thus provides the efficientmeans to regulate the differential
cell junction restructuring event at the Sertoli and the Sertoli germ cell
interface. This is also physiologically necessary, perhaps essential,
because at least 30–50 germ cells at different stages of their develop-
ment are intimately associated with a single Sertoli cell in the seminif-
erous epithelium (39). As such, extensive but rapid restructuring can
take place along the entire Sertoli cell surface from the basal to the apical
(i.e. adluminal) portions of the cell via this switchingmechanism to open
or close TJ and/or AJ. Furthermore, results reported herein have unrav-
eled a new in vivo model to study BTB dynamics because the use of
TGF-3 administered locally to the testis for studying BTB dynamics
has fulfilled several important criteria. First, TGF-3 is a natural sub-
stance released by Sertoli and germ cells, unlike other models that
sought the use of a toxicant, such as cadmium or glycerol. Second, its
disruptive effects to the BTB integrity and germ cell loss is reversible,
unlike the cadmium and glycerol models whose damaging effects to the
BTB are irreversible (20, 37). The fact that both germ cells could repop-
ulate the epithelium and the TGF-3-induced BTB damage could be
resealed suggest that the dose (i.e. 200 ng of TGF-3 per testis) that was
used was not cytotoxic, consistent with results of earlier in vitro studies
(11, 24). In this context, one may argue that the amount of TGF-3 that
was administered to each test animal at 200 ng/testis might not have
reflected the physiological level of TGF-3 at the BTB at stage VII–VIII
when preleptotene and leptotene spermatocytemigrate across the BTB.
To address this possibility, at least in part, we had performed immuno-
blot analysis as described under “Experimental Procedures” to assess the
relative level of TGF-3 in adult rat testes. It was shown that each adult
rat testis contained1.1 0.2 g of TGF-3, illustrating the adminis-
tered dose at 200 ng per testis is within the physiological range. Further-
more, target genes that are important to junction disruption as well as
“resealing” can nowbe identified and studied by using thismodel. Third,
the entire experiment took a relatively short period of time to complete,
only 28 days, which include TGF-3 recombinant protein adminis-
protein transfers from blots onto nitrocellulose membranes. D, data shown in C were scanned and summarized in these two histograms with n  3. E, testis lysates (500 g of
protein/sample) from adjudin-treated rats were used for Co-IP with an anti-TRI antibody, and protein-protein interactions between TR1 and CD2AP, Ras, or TAB1 were examined
by immunoblottings (left panel). Protein lysates without Co-IP was shown in the right panel. F, histograms using data shown in Ewith n 3. ns, not significantly different by ANOVA;
*, p 0.05; **, p 0.01; h, hour; d, day.
FIGURE 8. A schematic drawing that illustrates the intriguing association between
CD2AP, TAB1, andTR1 (type1 receptor for TGF-) can selectivelydisruptBTBand
Sertoli germ cell adhesion or Sertoli germ cell adhesion alone. This schematic draw-
ing summarizes the results of the experiments reported herein. It illustrates that the
differential interactions of TAB1 and CD2AP with the TGF-3-TR1 complex in the sem-
iniferous epithelium can activate downstream signal transducers p38 and/or ERK. For
instance, the association of the TGF-3-TR1 complex with adaptors TAB1 and CD2AP
activates both p38 and/or ERK, perturbing BTB and AJ. However, if this protein complex
only associates with CD2AP but not TAB1, it activates only ERK, selectively perturbing AJ
without compromising the BTB.
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tration, transient BTB and Sertoli germ cell adhesion damage, and full
recovery (e.g. germ cell repopulation) in the testis. Thus, the experimen-
tal protocol is not time consuming, and it does not require the use of
sophisticated equipment.
Adaptors TAB1 and CD2AP Are Molecular Switches in the Testis
That Select the Downstream Signal Transducer of TGF-3 to Reversibly
Disrupt BTB and AJ via p38 MAPK or AJ Alone via ERK—In this con-
text, it is of interest to note that TAB1 is an adaptor that is known to be
expressed in almost all tissues examined to date, including the testis, and
it is known to interact with TAK1 (TGF--activated kinase 1) to facili-
tate the activation of TAK1 by TGF- receptors (40). CD2AP was orig-
inally identified as an adaptor that facilitated the formation of special-
ized junctions betweenT cells and antigen-presenting cells (41) andwas
found to be essential to maintain renal glomerulus epithelial junctions,
known as the slit diaphragm, because CD2AP/mice died from renal
failure by 6 weeks postpartum (42). Interestingly, restoring the
expression of CD2AP in the kidney was shown to prolong the life
expectancy of these knock-out mice, yet the aging testes displayed pro-
gressive defects in spermatogenesis, possibly as a result of BTB break-
down (30). In the kidney, CD2AP preferentially directs TGF--medi-
ated signaling to ERK instead of p38 MAPK (43), and this mechanism
was shown to be used by the testis to transmit TGF-3-induced signal-
ing to regulate Sertoli germ cell adhesion as reported herein without
perturbing the BTB (see Fig. 8) (14). It is likely that the lack of CD2AP in
the seminiferous epithelium in these CD2AP knock-out mice can plau-
sibly skew the TGF-3-mediated signals toward the p38 MAPK path-
way, and this thus disrupts the BTB, leading to defects in spermatogen-
esis as earlier reported (30). CD2AP has been shown to interact with
multiple regulatory partners, such as phosphatidylinositol 3-kinase,
p130 Cas, and proteins related to actin dynamics and endocytosis (44),
and these kinases (e.g. phosphatidylinositol 3-kinase and c-Src) have
been shown to be putative regulators of Sertoli germ cell adhesion in the
rat testis (16). The demonstration that CD2AP interacts with N-cad-
herin, -catenin, and ZO-1, but not occludin, at the BTB and with
members in the TGF-3/TR1/ERK signaling cascade further
strengthens the notion regarding the crucial role of CD2AP in junction
dynamics in the testis. In this context, it is of interest to note that one can
argue with the conclusion of this study because these results were
acquired based on two relatively new models, namely the TGF-3
model and the adjudin model in the field. However, studies that were
based on these models have been validated using specific inhibitors
against different signal transducers, such as SB202190 (a specific inhib-
itor of p38 MAPK (12, 35, 45)) and Y-27632 (a specific inhibitor ROCK
inhibitor (46, 47, 48)) in the TGF-3 and adjudin model, respectively.
Needless to say, future studies should include an examination of TGF-
3-specific knock-out mice versus testis-specific overexpression of
TGF-3 regarding the status of BTB and spermatogenesis. Also, the
levels of TGF-3 in staged tubules at VII–VIII should also be quantified
versus other stages. Nonetheless, results presented herein have shown
that these models can now be used by investigators in the field to study
junction dynamics pertinent to germ cell movement across the BTB, as
well as from the basal compartment to the luminal edge of the seminif-
erous tubule during spermatogenesis.
Summary and Conclusions—As reported herein, the TGF-3-TR1-
TAB1-CD2AP protein complex is one of the crucial regulatory protein
complexes that induces transient disruption of BTB to facilitate prelep-
totene and leptotene spermatocyte migration across the BTB and the
release of fully developed spermatids at spermiation by perturbing api-
cal ES (see Fig. 8). It is obvious that this work should be expanded in
future studies to prepare transgenic mice in which Sertoli cell TGF-3
can be switched on and off to examine the subsequent effects on BTB
function. Furthermore, results reported in this paper have shown that in
vivo administration of TGF-3 to adult rat testes is a novel model for
studying BTB dynamics. In this context, it is of interest to note that
other members of the TGF- family, and perhaps other cytokines, may
work in concert with TGF-3 to regulate BTB dynamics during sper-
matogenesis (for a review see Ref. 14). For instance, earlier in vitro
studies have shown that the assembly of Sertoli cell TJ permeability
barrier in vitro was also associated with a decline in the steady-state
TGF-2 mRNA level (11). Additionally, Sertoli and germ cells are
known to produce an array of cytokines both in vitro and in vivo (25, 49).
This possibility should be carefully evaluated in future studies.
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